Monsanto Gets a Hold Rating from Jefferies

By Carrie Williams

Jefferies analyst Laurence Alexander reiterated a Hold rating on Monsanto (NYSE: MON) yesterday and set a price target of $128. The company’s shares closed yesterday at $118.27, close to its 52-week high of $118.97.

According to, Alexander is a top 100 analyst with an average return of 13.8% and a 71.0% success rate. Alexander covers the Consumer Goods sector, focusing on stocks such as Air Products and Chemicals, Sherwin-Williams Company, and GCP Applied Technologies.

Currently, the analyst consensus on Monsanto is Moderate Buy and the average price target is $126.40, representing a 6.9% upside.

In a report issued on September 5, RBC Capital also reiterated a Hold rating on the stock with a $128 price target.

Based on Monsanto’s latest earnings report for the quarter ending May 31, the company posted quarterly revenue of $4.23 billion and quarterly net profit of $843 million. In comparison, last year the company earned revenue of $2.57 billion and had a GAAP net loss of $191 million.

Based on the recent corporate insider activity of 106 insiders, corporate insider sentiment is negative on the stock. Most recently, in July 2017, Robert Fraley, the EVP & CTO of MON sold 52,410 shares for a total of $6,181,235.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Monsanto Co. engages in the provision of agricultural products to farmers. The company operates its business through the following business segments: Seeds & Genomics and Agricultural Productivity.